Parametric Portfolio Associates’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.89M | Sell |
17,086
-1,415
| -8% | -$156K | ﹤0.01% | 2447 |
|
|
2021
Q4 | $1.78M | Sell |
18,501
-1,041
| -5% | -$100K | ﹤0.01% | 2501 |
|
|
2021
Q3 | $1.71M | Buy |
19,542
+8,044
| +70% | +$702K | ﹤0.01% | 2525 |
|
|
2021
Q2 | $1.78M | Buy |
11,498
+5,624
| +96% | +$871K | ﹤0.01% | 2498 |
|
|
2021
Q1 | $927K | Buy |
5,874
+609
| +12% | +$96.1K | ﹤0.01% | 3201 |
|
|
2020
Q4 | $1.22M | Buy |
5,265
+2,229
| +73% | +$518K | ﹤0.01% | 2942 |
|
|
2020
Q3 | $665K | Sell |
3,036
-6,604
| -69% | -$1.45M | ﹤0.01% | 3125 |
|
|
2020
Q2 | $2.74M | Sell |
9,640
-914
| -9% | -$260K | ﹤0.01% | 2299 |
|
|
2020
Q1 | $3.04M | Buy |
10,554
+3,794
| +56% | +$1.09M | ﹤0.01% | 2108 |
|
|
2019
Q4 | $1.94M | Buy |
6,760
+5,076
| +301% | +$1.46M | ﹤0.01% | 2706 |
|
|
2019
Q3 | $243K | Buy |
1,684
+257
| +18% | +$37.1K | ﹤0.01% | 3633 |
|
|
2019
Q2 | $128K | Buy |
+1,427
| New | +$128K | ﹤0.01% | 3809 |
|
|
2017
Q3 | – | Sell |
-1,306
| Closed | -$177K | – | 4039 |
|
|
2017
Q2 | $177K | Sell |
1,306
-560
| -30% | -$75.9K | ﹤0.01% | 3845 |
|
|
2017
Q1 | $359K | Buy |
1,866
+519
| +39% | +$99.9K | ﹤0.01% | 3360 |
|
|
2016
Q4 | $190K | Buy |
1,347
+19
| +1% | +$2.68K | ﹤0.01% | 3603 |
|
|
2016
Q3 | $194K | Buy |
+1,328
| New | +$194K | ﹤0.01% | 3577 |
|
|
2015
Q3 | – | Sell |
-753
| Closed | -$307K | – | 3304 |
|
|
2015
Q2 | $307K | Buy |
+753
| New | +$307K | ﹤0.01% | 3558 |
|
|
2015
Q1 | – | Sell |
-747
| Closed | -$419K | – | 3973 |
|
|
2014
Q4 | $419K | Buy |
+747
| New | +$419K | ﹤0.01% | 3363 |
|